| Radiotherapy or chemotherapy as the initial treatment for stage IIIA Hodgkin's disease (Report no 13). | |
| | |
MedLine Citation:
|
PMID: 7273647 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This report describes three comparative studies of treatment methods in patients with Stage IIIA Hodgkin's disease in whom the extent of disease had been confirmed by a diagnostic laparotomy. The first trial (1970-75) compared TNI with MOPP. The recurrence-free survival curve for patients treated with TNI was significantly better than that for those treated with MOPP at four years, but the survival rate of the two cohorts was identical, presumably because of good salvage treatment. The second study (1975-80) compared TNI with TNI followed by LOPP. Initially the addition of LOPP appeared to improve the disease-free survival rate but at three years no difference was apparent between the two treatment groups. The third (1980-present) study divides patients into those with and those without splenic involvement. Retrospective analysis of all patients included in the BNLI with Stage IIIA Hodgkin's disease confirmed by laparotomy and treated initially by TNI shows that splenic involvement does not influence the survival but decreases the relapse-free survival rate, making additional treatment with MOPP necessary in 75% of long-term survivors. In the current study, patients without splenic involvement are treated with TNI whereas those with splenic involvement are treated initially with chemotherapy, randomising between MOPP and LOPP. |
| | |
Authors:
|
P Strickland |
Related Documents
:
|
10505027 - Retrospective assessment of quality of life and treatment outcome in patients with hodg... 6547377 - Localised grade 2 non-hodgkin's lymphoma: results of treatment with radiotherapy (bnli ... 3194187 - Alternating chemotherapy and radiation therapy in the treatment of advanced hodgkin's d... 594947 - Lung carcinoma after radiotherapy and chemotherapy for hodgkin's disease. 6749057 - Influence of local-regional lymph node metastases on prognosis in neuroblastoma. 22475637 - Lymphoma of the thyroid and head and neck. |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Clinical radiology Volume: 32 ISSN: 0009-9260 ISO Abbreviation: Clin Radiol Publication Date: 1981 Sep |
Date Detail:
|
Created Date: 1981-11-22 Completed Date: 1981-11-22 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 1306016 Medline TA: Clin Radiol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 527-30 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Chlorambucil
/
therapeutic use Drug Therapy, Combination Hodgkin Disease / drug therapy*, mortality, radiotherapy* Humans Laparotomy Mechlorethamine / therapeutic use Neoplasm Staging Prednisone / therapeutic use Procarbazine / therapeutic use Splenic Neoplasms / drug therapy Vincristine / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
305-03-3/Chlorambucil; 51-75-2/Mechlorethamine; 53-03-2/Prednisone; 57-22-7/Vincristine; 671-16-9/Procarbazine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The place of radiotherapy in the management of localised Hodgkin's disease (Report no 11).
Next Document: Complications in the management of the malignant lymphomas (Report no 15).